Nuveen Asset Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $17.6M | Sell |
373,229
-9,947
| -3% | -$468K | 0.01% | 1260 |
|
2024
Q3 | $20.2M | Buy |
383,176
+28,035
| +8% | +$1.48M | 0.01% | 1190 |
|
2024
Q2 | $19.2M | Sell |
355,141
-144,460
| -29% | -$7.83M | 0.01% | 1157 |
|
2024
Q1 | $35M | Buy |
499,601
+156,000
| +45% | +$10.9M | 0.01% | 822 |
|
2023
Q4 | $28.7M | Sell |
343,601
-26,023
| -7% | -$2.17M | 0.01% | 915 |
|
2023
Q3 | $10.9M | Buy |
369,624
+2,462
| +0.7% | +$72.5K | ﹤0.01% | 1427 |
|
2023
Q2 | $12M | Buy |
367,162
+22,253
| +6% | +$726K | ﹤0.01% | 1388 |
|
2023
Q1 | $12.1M | Sell |
344,909
-14,697
| -4% | -$517K | ﹤0.01% | 1363 |
|
2022
Q4 | $16.5M | Sell |
359,606
-2,747
| -0.8% | -$126K | 0.01% | 1171 |
|
2022
Q3 | $17.6M | Buy |
362,353
+1,344
| +0.4% | +$65.1K | 0.01% | 1108 |
|
2022
Q2 | $14.2M | Buy |
361,009
+102,426
| +40% | +$4.02M | 0.01% | 1283 |
|
2022
Q1 | $9.2M | Sell |
258,583
-1,707
| -0.7% | -$60.7K | ﹤0.01% | 1697 |
|
2021
Q4 | $9.51M | Sell |
260,290
-22,259
| -8% | -$814K | ﹤0.01% | 1727 |
|
2021
Q3 | $9.58M | Buy |
282,549
+25,117
| +10% | +$851K | ﹤0.01% | 1812 |
|
2021
Q2 | $5.1M | Sell |
257,432
-38,434
| -13% | -$761K | ﹤0.01% | 2237 |
|
2021
Q1 | $6.88M | Sell |
295,866
-73,338
| -20% | -$1.71M | ﹤0.01% | 2001 |
|
2020
Q4 | $7.67M | Sell |
369,204
-175,396
| -32% | -$3.64M | ﹤0.01% | 1863 |
|
2020
Q3 | $11.8M | Buy |
544,600
+247,892
| +84% | +$5.37M | ﹤0.01% | 1414 |
|
2020
Q2 | $6.99M | Buy |
296,708
+50,165
| +20% | +$1.18M | ﹤0.01% | 1711 |
|
2020
Q1 | $2.91M | Buy |
246,543
+492
| +0.2% | +$5.8K | ﹤0.01% | 2007 |
|
2019
Q4 | $2.61M | Sell |
246,051
-174,381
| -41% | -$1.85M | ﹤0.01% | 2317 |
|
2019
Q3 | $4.79M | Buy |
420,432
+224,569
| +115% | +$2.56M | ﹤0.01% | 1978 |
|
2019
Q2 | $2.2M | Buy |
+195,863
| New | +$2.2M | ﹤0.01% | 2388 |
|